A Legacy of Hope and Determination
Professor Richard Scolyer AO, one of the world’s most respected cancer pathologists, has passed away after a courageous battle with an aggressive form of brain cancer. His journey was marked by resilience, dedication, and an unwavering commitment to improving the lives of others. Despite his terminal diagnosis, Richard continued to work, advocate for cancer research, and even compete in athletic events well beyond what was expected.
His family shared a heartfelt open letter titled “To All Australians” through his social media accounts on the day of his passing. This letter reflected the deep impact he had on the lives of many, both personally and professionally.
As co-medical director of the Melanoma Institute Australia, Richard played a pivotal role in advancing immunotherapy treatments alongside Professor Georgina Long. Their groundbreaking work saved thousands of lives and significantly altered the course of melanoma treatment.
Richard was a passionate advocate for sun-safe behaviour and melanoma prevention. However, it was his own battle with Grade-IV IDH-wildtype glioblastoma that captured the nation’s attention and admiration. When he publicly decided to pursue an experimental treatment for his terminal tumour, the public closely followed his journey, inspired by his strength and determination.
In early 2025, Richard made a difficult announcement that his tumour had returned. Yet, he found comfort in the optimistic data generated from his experimental treatment. In a final interview with The Weekly, he expressed hope that this treatment could change the future for other brain cancer patients.
A Life Dedicated to Others
Born in Launceston in 1966, Richard’s childhood was shaped by challenges, including his mother suffering a series of strokes. Despite this, his memories were largely positive. His intelligence and leadership abilities became evident during his school years. As he began working in pathology, his drive and passion for his profession quickly emerged.
His professional achievements were not driven by a desire for personal success but by a genuine wish to ensure patients received accurate diagnoses so they could access the best possible treatment and return to good health. In a 2024 interview with The Weekly, Richard emphasized that his goal was always to make a difference in people’s lives.
He took a job in Canberra, often driving three hours each Wednesday afternoon to attend a session called “Too Hards” at the University of Sydney, followed by a lecture at Royal Prince Alfred Hospital. These sessions allowed pathologists to share challenging cases, and they ignited a fire within Richard. “I loved recognizing things that were really rare,” he said. “I pushed myself pretty hard.”
Richard eventually moved to Sydney, where he met his wife, Dr Katie Nicholl. Together, they raised three children: Emily, Matthew, and Lucy. For decades, Richard worked tirelessly to improve cancer treatments and outcomes. In January 2024, he was jointly named Australian of the Year with Professor Georgina Long.
In September 2025, Prime Minister Anthony Albanese announced $5.9 million in funding to establish the Richard Scolyer Chair in Brain Cancer Research. This initiative aims to accelerate research into brain cancer and expand clinical trials.
Speaking at the event, Richard expressed his lifelong dedication to making a difference in people’s lives. His legacy will continue to inspire future generations of researchers, medical professionals, and patients alike.
Our condolences go out to the Scolyer family and all those whose lives were touched by Richard. From all at The Australian Women’s Weekly team.
Vale Richard Scolyer AO.
